177 related articles for article (PubMed ID: 23955801)
1. Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis.
Duan CY; Liu MY; Li SB; Ma KS; Bie P
Tumour Biol; 2014 Jan; 35(1):659-66. PubMed ID: 23955801
[TBL] [Abstract][Full Text] [Related]
2. Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis.
Wang Z; Cao Y; Jiang C; Yang G; Wu J; Ding Y
PLoS One; 2012; 7(6):e40039. PubMed ID: 22768213
[TBL] [Abstract][Full Text] [Related]
3. Association between microsomal epoxide hydrolase 1 polymorphisms and susceptibility to esophageal cancer: a meta-analysis.
Zhao W; Luo J; Cai X
Tumour Biol; 2013 Aug; 34(4):2383-8. PubMed ID: 23681797
[TBL] [Abstract][Full Text] [Related]
4. Lack of association of MiR-34b/c polymorphism (rs4938723) with hepatocellular carcinoma: a meta-analysis.
Liang TJ; Liu HJ; Zhao XQ; Yu CH; Li CS
PLoS One; 2013; 8(7):e68588. PubMed ID: 23935875
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma.
Zhong JH; Xiang BD; Ma L; You XM; Li LQ; Xie GS
PLoS One; 2013; 8(2):e57064. PubMed ID: 23451147
[TBL] [Abstract][Full Text] [Related]
7. [EPHX1 Tyr113His polymorphism contributes to hepatocellular carcinoma risk: evidfnce from a meta-analysis].
Wang D; Zhai JX; Zhang LM; Liu DW; Liu XH
Mol Biol (Mosk); 2015; 49(2):351-61. PubMed ID: 26065263
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.
Liu F; Yuan D; Wei Y; Wang W; Yan L; Wen T; Xu M; Yang J; Li B
PLoS One; 2012; 7(8):e43821. PubMed ID: 22928041
[TBL] [Abstract][Full Text] [Related]
9. XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis.
Zhou Q; Fu Y; Wen L; Deng Y; Chen J; Liu K
Technol Cancer Res Treat; 2021; 20():1533033821990046. PubMed ID: 33517857
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects.
Yang X; Wang Y; Wang G
J Exp Clin Cancer Res; 2014 Sep; 33(1):82. PubMed ID: 25261893
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between EPHX1 polymorphism and esophageal cancer risk: evidence from meta-analysis.
Yan YL; Chen X; Liang HJ; Wang J; Li TJ; Li RL; Li S; Qin X
Dis Esophagus; 2015; 28(2):164-71. PubMed ID: 25714851
[TBL] [Abstract][Full Text] [Related]
12. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
Li JF; Zheng EQ; Xie M
Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
[TBL] [Abstract][Full Text] [Related]
13. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of the effects of the EPHX1 Tyr113His polymorphism on lung and breast cancer.
Tan X; Wang YY; Chen XY; Xian L; Guo JJ; Liang GB; Chen MW
Genet Mol Res; 2014 Sep; 13(3):7437-46. PubMed ID: 25222243
[TBL] [Abstract][Full Text] [Related]
15. Association between esophageal cancer risk and EPHX1 polymorphisms: a meta-analysis.
Li QT; Kang W; Wang M; Yang J; Zuo Y; Zhang W; Su DK
World J Gastroenterol; 2014 May; 20(17):5124-30. PubMed ID: 24803829
[TBL] [Abstract][Full Text] [Related]
16. Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer.
Wang S; Zhu J; Zhang R; Wang S; Gu Z
Tumour Biol; 2013 Apr; 34(2):1045-52. PubMed ID: 23378225
[TBL] [Abstract][Full Text] [Related]
17. Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis.
An PP; Feng LN; Zhang XX; Jin QL
Medicine (Baltimore); 2020 Dec; 99(50):e23659. PubMed ID: 33327352
[TBL] [Abstract][Full Text] [Related]
18. Association between polymorphisms of microsomal epoxide hydrolase and COPD: results from meta-analyses.
Hu G; Shi Z; Hu J; Zou G; Peng G; Ran P
Respirology; 2008 Nov; 13(6):837-50. PubMed ID: 18811882
[TBL] [Abstract][Full Text] [Related]
19. Associations between Cox-2 rs20417 and rs5275 polymorphisms and the risk of hepatocellular carcinoma: a meta analysis.
Wu H; Wu X; Wan G; Zhang S
Int J Clin Exp Pathol; 2014; 7(10):6898-905. PubMed ID: 25400773
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis demonstrates lack of a relationship between XRCC1-399 gene polymorphisms and susceptibility to hepatocellular carcinoma.
Zeng XY; Huang JM; Xu JW; Xu Y; Yu HP; Ji L; Qiu XQ
Genet Mol Res; 2013 Jun; 12(2):1916-23. PubMed ID: 23546985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
